Alphyn Biologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, today announced the close of its $25 million, twice-oversubscribed Series B financing ...
The holiday season is a time for family, warmth, and well-being--but winter conditions can also make breathing less comfortable for many seniors and adults. Cold weather, dry indoor air, and seasonal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback